Growing evidence supports the notion that serum NAPDH oxidase 2 (NOX2) is an important regulator that contributes to the initiation and progression of various types of diseases. However, so far, it remains elusive about the relationship between levels of serum NOX2 and HBV-related diseases. The overall purpose of the study is to get a better insight into whether or not serum NOX2 is involved in HBV-related disorders. Serum levels of NOX2, from 105 patients with chronic hepatitis B, 58 patients with HBV-related cirrhosis, 48 patients with HBV-related hepatocellular carcinoma and 104 healthy individuals, were measured with sandwich ELISA kits that we developed. In this study, we found that NOX2 values were significantly higher in patients compared to healthy control (P < 0.01) and that the levels of serum NOX2 were significantly correlated with the serum levels of superoxide dismutase (SOD), interleukin-6 (IL-6), interferon-stimulated gene 15 (ISG15), alkaline phosphatase (ALP) and gamma glutamyl transpeptidase (GGT) in chronic hepatitis B, cirrhosis and hepatocellular carcinoma patients. Interestingly, we found that a significant positive correlation between NOX2 and HBV viral load only in patients with chronic hepatitis B and cirrhosis. Therefore, Serum NOX2 levels maybe an important indicator of the pathogenesis of progression of HBV-related disorders.
Keywords: Hepatitis B virus; NOX2; ROS; chronic hepatitis B; cirrhosis; hepatocellular carcinoma.
Conflict of interest statement
Soluble E-cadherin as a serum biomarker in patients with HBV-related liver diseases.Clin Biochem. 2016 Nov;49(16-17):1232-1237. doi: 10.1016/j.clinbiochem.2016.07.011. Epub 2016 Jul 22. Clin Biochem. 2016. PMID: 27452182
Association of IL-2 polymorphisms and IL-2 serum levels with susceptibility to HBV-related hepatocellular carcinoma in a Chinese Zhuang population.Infect Genet Evol. 2014 Oct;27:375-81. doi: 10.1016/j.meegid.2014.08.021. Epub 2014 Aug 27. Infect Genet Evol. 2014. PMID: 25173083
Correlation of serum hepcidin levels with disease progression in hepatitis B virus-related disease assessed by nanopore film based assay.Sci Rep. 2016 Oct 3;6:34252. doi: 10.1038/srep34252. Sci Rep. 2016. PMID: 27694815 Free PMC article. Clinical Trial.
What can we learn from hepatitis B virus clinical cohorts?Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716. Liver Int. 2015. PMID: 25529093 Review.
Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.Princess Takamatsu Symp. 1995;25:27-32. Princess Takamatsu Symp. 1995. PMID: 8875606 Review.